technology

in-house technology

Our state-of-the-art technology comprises two production commercial lines dedicated to the manufacture of oncology vial injectables.
Biomolecules are processed using a single-use system technology connected to the isolator concept line.

Our leading expertise includes aseptic processing of aqueous and non-aqueous liquid, terminally sterilized, and freeze-dried products in clinical and commercial scale.

production line 1

Production line 1 uses a conventional cleanroom concept that allows us to produce batches from 10 to 1,000 litres using a stainless steel technology. Our line 1 features two freeze dryers with shelf area of 17 sqm each. The vial fill volumes range between 1 ml and 200 ml.

production line 2

Production line 2 uses an isolator concept and allows us to produce batches from 2 to 1,000 litres using a stainless steel or a single-use system technology. Our line 2 features one freeze dryer with shelf area of 12 sqm and is equipped with a dual cooling system and a solvent separator to process non-aqueous formulations. The vial fill volumes range between 0.5 ml and 100 ml.

production line 3

Production line 3 will be focused on production of syringes and cartridges. The line will use a stainless steel or a single-use system technology and its capacity will be more than 100 million syringes/cartridges per year in volumes from 1 up to 500 litres. A dual filling system will feature a time-pressure system and a peristaltic pump with a speed of 600 pcs/min. The syringe/cartridges filling volumes will range between 0.5 ml and 20 ml.

production lines comparison

Line 1

Manufacturer: Gröninger

Concept

Clean room

Line 2

Manufacturer: IMA

Concept

Isolator

Line 3 (in progress)

Manufacturer: Syntegon

Concept

Isolator

Formulation & Aseptic filtration

Stainless steel concept
min. batch size approx. 10 l
max. batch size 1,000 l
Filter size: 5 and 10 inch

 

Formulation & Aseptic filtration

Stainless steel concept
min. batch size approx. 10 l
max. batch size: 1,000 l
Filter size: 5 inch

Single use system

min. batch size approx. 2 l
max. batch size: 500 l
Custom design option

Formulation

Stainless steel concept
min. batch size approx. 1 l
max. batch size: 500 l

Single use system

min. batch size approx. 2 l
max. batch size: 500 l
Custom design option

Filling Line

Vial formats 6 ml to 200 ml
Fill volumes from 1 ml to 200 ml
Automatic statistical weight control
Speed – approx. 6000 pcs/hour, 20 ml vial

Filling Line

Vial formats 2 ml to 100 ml
Fill volumes from 0.5ml to 100 ml
100% weight control
Speed – approx. 6000 pcs/hour, 20 ml vial

Filling Line

Syringe and cartridge formats
1 ml to 50 ml
Fill volumes up to 500 l
Automatic weight control
Speed – approx. 28.500 pcs/hour

Freeze Drying

2 freeze dryers, 17 sqm each
Approx. 20,000 20 ml vials
Lowest shelf temperature: -55 °C
Lowest ice-condenser temperature: -85 °C – compressor
Ice capacity: 300 kg
Manufacturer: GEA

Freeze Drying

1 freeze dryer, 12 sqm
Approx. 13,000 20 ml vials
Dual cooling system
Lowest shelf temperature: -60 °C
Lowest ice-condenser
temperature: -75 °C – compressor
-90 °C – liquid nitrogen
Ice capacity: 200 kg
Solvent separator
Manufacturer: GEA

Terminal Sterilization

1 autoclave, 3,000 l chamber
Manufacturer: STERIS

Optical Inspection

Semi-automated Seidenader equipment, manual optical inspection

Secondary Packaging

Automatic line, manual packaging

Terminal Sterilization

1 autoclave, 3,000 l chamber

Optical Inspection

Semi-automated Seidenader equipment, manual optical inspection

Secondary Packaging

Automatic line, manual packaging

Optical Inspection

Automated Syntegon equipment

a technologically
specialized CDMO

As a specialized CDMO we bring our expertise to sterile processing and aseptic Fill & Finish of complex formulations. We master high-potent and cyto and provide access to our niche in-house technology. No additional investments of our pharmaceutical partners are needed due to the access to variable equipment sizes supported by qualified processes and transparent service offering.

We are fast, flexible and agile because we bring together advanced scientific and technical capabilities and experience, responsiveness and innovation in order to accommodate unique needs of each of our strategic partners as they navigate the dynamic drug development process.

Thanks to our authentic and brave approach rooted in our state-of-the-art technology and knowledge, you, as a partner, can dare to act with courage too and ask for advanced and highly active drug solutions. We (and our technology) will support you.

niche technologies

HPAPI handling & processing

Highly potent and toxic substances (OEB 3 – OEB 6) are handled using HIGH-TECH containment technology and processes which are OHSAS 18001 certified.

organic solvents
handling & processing

Organic solvents are handled using unique developed processes and upgraded equipment accessories which allows us to process organic solvents also in freeze-drying. 

freeze-drying

Freeze-dryers are equipped with Automatic Loading and Unloading System placed in Class A. Loading directly on
pre-cooled shelves assures protection of temperature sensitive products.

sensitive products 

Formulation vessels, product pipeline and filter housings are temperature controlled. Red light is used for processing light sensitive products. Nitrogen is applied in every production step.

single use system 

No cross-contamination of small molecules and biomolecules thanks to custom systems of specific drug production. SUS technology to minimize losses when High Price APIs are handled.  

where courage meets knowledge